Clinical trial
Prospective, Multicenter, Epidemiological Study To Determine The Clinical, Molecular And Genetic Factors Associated To The Prognosis Of Patients With Advanced Renal Cell Carcinoma
NCT00927043 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter, Epidemiological Study To Determine The Clinical, Molecular And Genetic Factors Associated To The Prognosis Of Patients With Advanced Renal Cell Carcinoma
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- September 30, 2011
- Enrollment
- 145 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.